Similar articles

• Recurrence of cutaneous melanoma of the head and neck after negative sentinel lymph node biopsy.

  Davis-Malesevich MV, Goepfert R, Kubik M, Roberts DB, Myers JN, Kupferman ME. Davis-Malesevich MV, et al. Head Neck. 2015 Aug;37(8):1116-21. doi: 10.1002/hed.23718. Epub 2014 Jul 11. Head Neck. 2015. PMID: 24764188
• Sentinel lymph node biopsy: is it an evolution of the management of cutaneous melanoma?

  De Giorgi V, Grazzini M, Papi F, Gori A, Rossari S, Lotti T. De Giorgi V, et al. Ann Surg Oncol. 2011 Feb;18(2):597; author reply 598-9. doi: 10.1245/s10434-010-1067-3. Epub 2010 Apr 22. Ann Surg Oncol. 2011. PMID: 20411434 No abstract available.
• Evolving treatment strategies in thin cutaneous head and neck melanoma: 1 institution's experience.

  Jaber JJ, Clark JI, Muzaffar K, Ruggiero FP, Feustel PJ, Frett MJ, Zender CA. Jaber JJ, et al. Head Neck. 2011 Jan;33(1):7-12. doi: 10.1002/hed.21403. Head Neck. 2011. PMID: 20848424
• The role of sentinel lymph node biopsy in the management of thin melanoma.

  Wong SL. Wong SL. Am J Surg. 2005 Aug;190(2):196-9. doi: 10.1016/j.amjsurg.2005.05.011. Am J Surg. 2005. PMID: 16023430 Review.
• Management of early-stage cutaneous melanoma.

  Aloia TA, Gershenwald JE. Aloia TA, et al. Curr Probl Surg. 2005 Jul;42(7):460-534. doi: 10.1067/j.cpsurg.2005.04.002. Curr Probl Surg. 2005. PMID: 16099230 Review. No abstract available.